Citius Oncology, Inc. (CTOR)
0.7003
+0.03
(+4.37%)
USD |
NASDAQ |
Oct 21, 16:00
Citius Oncology Price : 0.7003 for Oct. 21, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | 0.7050 | 0.76 | 0.6523 | 0.7003 | 22887.00 |
| Oct 20, 2026 | 0.73 | 0.7467 | 0.6601 | 0.671 | 97445.00 |
| Oct 19, 2026 | 0.7562 | 0.7599 | 0.70 | 0.7104 | 40000.00 |
| Oct 16, 2026 | 0.7699 | 0.7699 | 0.75 | 0.7679 | 11706.00 |
| Oct 15, 2026 | 0.76 | 0.7699 | 0.7451 | 0.746 | 11061.00 |
| Oct 14, 2026 | 0.811 | 0.811 | 0.75 | 0.7836 | 27567.00 |
| Oct 13, 2026 | 0.80 | 0.8435 | 0.7425 | 0.792 | 96914.00 |
| Oct 12, 2026 | 0.8598 | 0.8598 | 0.7798 | 0.8126 | 67959.00 |
| Oct 09, 2026 | 0.842 | 0.8799 | 0.80 | 0.8398 | 71049.00 |
| Oct 08, 2026 | 0.87 | 0.87 | 0.8201 | 0.835 | 56578.00 |
| Oct 07, 2026 | 0.8469 | 0.9013 | 0.8469 | 0.851 | 105505.0 |
| Oct 06, 2026 | 0.858 | 0.9199 | 0.8121 | 0.85 | 109839.0 |
| Oct 05, 2026 | 0.93 | 0.93 | 0.8601 | 0.8735 | 85507.00 |
| Oct 02, 2026 | 0.9986 | 1.05 | 0.9144 | 0.95 | 208414.0 |
| Oct 01, 2026 | 1.07 | 1.07 | 0.9419 | 0.98 | 99593.00 |
| Sep 30, 2026 | 1.09 | 1.09 | 1.00 | 1.01 | 105949.0 |
| Sep 29, 2026 | 1.025 | 1.130 | 1.00 | 1.05 | 186172.0 |
| Sep 28, 2026 | 1.04 | 1.08 | 1.02 | 1.03 | 43570.00 |
| Sep 25, 2026 | 1.07 | 1.07 | 1.02 | 1.05 | 26667.00 |
| Sep 24, 2026 | 1.03 | 1.080 | 1.007 | 1.05 | 40727.00 |
| Sep 23, 2026 | 1.05 | 1.07 | 0.985 | 1.01 | 56968.00 |
| Sep 22, 2026 | 1.00 | 1.12 | 0.9995 | 1.07 | 116994.0 |
| Sep 21, 2026 | 1.15 | 1.15 | 1.03 | 1.045 | 152197.0 |
| Sep 18, 2026 | 1.05 | 1.155 | 1.01 | 1.14 | 337514.0 |
| Sep 17, 2026 | 0.97 | 1.05 | 0.92 | 1.02 | 189396.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Citius Pharmaceuticals, Inc. | 0.385 |
| ACADIA Pharmaceuticals, Inc. | 20.39 |
| Alnylam Pharmaceuticals, Inc. | 225.17 |
| Anika Therapeutics, Inc. | 20.36 |
| Savara, Inc. | 4.68 |
Price Related Metrics
| PS Ratio | 9.273 |
| PEG Ratio | -0.0207 |
| Price to Book Value | 1.834 |
| Earnings Yield | -67.64% |
| Market Cap | 74.06M |
| PEGY Ratio | -0.0207 |